AVTX

6.7300.30%
GA

Garry A. Neil

President, CEO & Director

Dr. Garry A. Neil, M.D., serves as the Member of Scientific Advisory Board of Rapafusyn Research And Development, Inc. Dr. Garry serves as Independent Director of Celldex Therapeutics, Inc. since June 16, 2022. He has been President & Chief Executive Officer at Avalo Therapeutics, Inc. (formerly known as Cerecor Inc.) since February 14, 2022 and serves as its Director since June 14, 2022 and was its Chief Scientific Officer since March 2020 February 14, 2022 and served as its Chairman of the Board since August 08, 2022 until March 2025. He served as Chief Medical Officer at Avalo Therapeutics, Inc. (formerly known as Cerecor Inc.) since February 3, 2020 until March 2020. He served as Independent Director at Zura Bio Limited since March 21, 2023 until November 2023. Dr. Neil had been the Chief Scientific Officer of Aevi Genomic Medicine, Inc. since September 2013 until February 3, 2020. He served as Global Head of Research and Development at Medgenics, Inc. since September 13, 2013. He served as the Head of Research and Development at Braeburn Pharmaceuticals, Inc. He was a Partner at Apple Tree Partners from September 2012 to September 2013. He joined Apple Tree Partners in 2012. He served as an Interim Chief Executive Officer of TransCelerate BioPharma Inc. from September 2012 to January 1, 2013. He has clinical development experience in the life sciences industry, science, medicine and pharmaceutical industries, with pharmaceutical, science and technology research and development at Johnson & Johnson, AstraZeneca, Merck KGaA and Astra Merck. He served as the Corporate Vice President of Science & Technology at Johnson & Johnson from November 2007 to August 2012 and Group President of Johnson & Johnson Pharmaceutical Research and Development from September 2005 to November 2007. He held other senior positions at Johnson & Johnson. From 1993 to 2002, he held various other senior positions at Astra Zeneca, EMD Pharmaceuticals and Merck KGaA. He served as Vice President of R&D at Merck KGaA/EMD Pharmaceuticals. He served as Vice President of Clinical Research at Astra Zeneca and Astra Merck. He served as the Chairman of TransCelerate BioPharma Inc and serves as its Director. Dr. Neil had been Director at GTx, Inc. from September 2016 until its March 2019. He had been an Independent Director of Arena Pharmaceuticals, Inc. since February 2017 until March 11, 2022 and its Chair of the Board since February 2021 until March 11, 2022. He was a Director of the Reagan Udall Foundation from 2007 to 2021. He served as a Director of the Foundation For The National Institutes of Health Inc. from 2010 to 2012. He served as Director at Oncternal Therapeutics, Inc. He serves as a Director of the Center for Discovery and Innovation at Hackensack Meridian Health. He served as Member of Innovation Advisory Board of Mytrus, Inc. since March 18, 2014. He served as a Member of the Science Management review Board of the NIH from 2010 – 2012. He serves as a Member of Advisory Board of Lateral Investment Management LLC. He served as the Chairman of the Pharmaceutical Research and Manufacturers Association Foundation Board. He served as the Chairman of the Scientific Advisory Board of the Center for Advanced Biotechnology and Medicine (Rutgers). He served as the Chairman of the PhRMA Foundation Board. He serves as Director of FBB Biomed, Inc. Dr. Neil is a Fellow of the American College of Physicians, a Fellow of the American College of Gastroenterology. He has written more than 50 articles and book chapters. He has held academic positions at Ludwig Institute for Cancer Research, the University of Toronto, the University of Iowa College of Medicine and the University of Pennsylvania (adjunct). He is the 2007 discovery awardee of the American Geriatrics Society. Dr. Neil holds a Bachelor of Science degree from the University of Saskatchewan and an M.D. from the University of Saskatchewan, College of Medicine and completed his Postdoctoral Clinical Training in Internal Medicine and Gastroenterology at the University of Toronto. Dr. Neil completed a Postdoctoral Research Fellowship at the Research Institute of Scripps Clinic.

Positions